Piper Sandler's downgrade of AST SpaceMobile centers on an unusual competitive dependency. SpaceX is building a rival direct-to-cell network while its Falcon 9 rocket remains one of the vehicles AST uses to place BlueBird satellites in orbit.
Piper cut AST to neutral from overweight and reduced its price target to $54 from $98, according to the original report. The firm cited less confidence in the 2026 and 2027 deployment schedule and argued that SpaceX's spectrum strategy could increase competitive pressure. Reuters reported that SpaceX agreed to acquire an 800 MHz spectrum portfolio from Grain Management for about $8 billion, subject to regulatory approval.
The downgrade does not prove that SpaceX will restrict a customer's launches. That is a scenario raised by the analyst, not an observed action. AST also has agreements with multiple launch providers, which reduces but does not eliminate concentration risk. The practical question is whether alternatives can meet AST's schedule, payload requirements and cost targets if Falcon 9 capacity becomes less attractive.
AST's own disclosure shows both progress and slippage. Six BlueBird spacecraft were launched within 50 days, bringing the in-orbit total to 13. Yet the company's target of about 45 satellites moved from the end of 2026 to early 2027. BlueBirds 14, 15 and 16 were described as close to shipment, but a spacecraft ready to ship still needs a confirmed launch, successful deployment and commissioning.
The market reaction reflects how tightly AST's valuation is tied to timing. A delay can postpone beta service, revenue and partner activation while capital continues to be spent. The next decisive evidence is not another analyst target. It is the launch manifest, the performance of each deployed satellite and progress toward commercial coverage. SpaceX's growing ambition raises the competitive stakes, but AST's own execution remains the variable investors can measure most directly.